Galectin-3 cytotest in thyroid follicular neoplasia: A prospective, monoinstitutional study

Acta Cytologica

Volumn 53, Issue 5, 2009, Pages 533-539

  Pennelli, Gianmaria ^a   Mian, Caterina ^a   Pelizzo, Maria Rosa ^a   Naccamulli, Davide ^b   Piotto, Andrea ^a   Girelli, Maria Elisa ^a   Mescoli, Claudia ^a   Rugge, Massimo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Aspiration biopsy; Fine needle; Galectin 3; Thyroid cancer; Thyroid neoplasms

Indexed keywords

GALECTIN 3;

ADOLESCENT; ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; ASPIRATION CYTOLOGY; CHILD; CYTOPATHOLOGY; FEMALE; GALECTIN 3 CYTOTEST; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; THYROID FOLLICULAR CARCINOMA; THYROIDECTOMY;

ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; CHILD; FEMALE; GALECTIN 3; GOITER, NODULAR; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; ODDS RATIO; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; YOUNG ADULT;

EID: 69749101295     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000325381     Document Type: Article

References (28)

1. Ezzat S, Sarti DA, Cain DR, Braunstein GD: Thyroid incidentalomas: Prevalence by palpation and ultrasonography. Arch Intern Med 1994;154:1838-1840 (Pubitemid 24262001)
2. Burguera B, Gharib H: Thyroid incidentalomas: Prevalence, diagnosis, significance, and management. Endocrinol Metab Clin North Am 2000;29:187-203 (Pubitemid 30151896)
3. Gharib H: Fine-needle aspiration biopsy of thyroid nodules: Advantages, limitations, and effect. Mayo Clin Proc 1994;69:44-49 (Pubitemid 24016915)
4. Bahar G, Braslavsky D, Shpitzer T, Feinmesser R, Avidan S, Popovtzer A, Karl S: The cytological and clinical value of the thyroid "follicular lesion." Am J Otolaryngol 2003;24:217-220
5. Hamming JF, Goslings BM, van Steenis GJ, van Ravenswaay Claasen H, Hermans J, van de Velde CJ: The value of fine-needle aspiration biopsy in patients with nodular thyroid disease divided into groups of suspicion of malignant neoplasms on clinical grounds. Arch Intern Med 1990;150:113-116 (Pubitemid 20085210)
6. British Thyroid Association, Royal College of Physicians: Guidelines for the Management of Thyroid Cancer: Report of the Thyroid Cancer Guidelines Update Group. Second edition. Edited by P Perros. London, Royal College of Physicians, 2007
7. Baloch Z, LiVolsi VA, Henricks WH, Sebak BA: Encapsulated follicular variant of papillary thyroid carcinoma. Am J Clin Pathol 2002;118:603-605
8. Saggiorato E, De Pompa R, Volante M, Cappia S, Arecco F, Dei Tos AP, Orlandi F, Papotti M: Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: A proposal for clinical application. Endocr Relat Cancer 2005;12:305-317
9. Schlinkert RT, van Heerden JA, Goellner JR, Gharib H, Smith SL, Rosales RF, Weaver AL: Factors that predict malignant thyroid lesions when fine-needle aspiration is "suspicious for follicular neoplasm." Mayo Clin Proc 1997;72:913-916
10. Tuttle RM, Lemar H, Burch HB: Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid 1998;8:377-383 (Pubitemid 28252418)
11. Baloch ZW, Fleisher S, LiVolsi VA, Gupta PK: Diagnosis of "follicular neoplasm": A gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 2002;26:41-44
12. Sherman SI: Thyroid carcinoma. Lancet 2003;361:501-511
13. Yang RY, Liu FT: Galectins in cell growth and apoptosis. Cell Mol Life Sci 2003;60:267-276
14. Orlandi F, Saggiorato E, Pivano G, Puligheddu B, Termine A, Cappia S, De Giuli P, Angeli A: Galectin-3 is a presurgical marker of human thyroid carcinoma. Cancer Res 1998;58:3015-3020 (Pubitemid 28335081)
15. Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, Inohara H, Marandino F, Orlandi F, Nardi F, Vecchione A, Tecce R, Larsson O; Thyroid Cancer Study Group: Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 2001;357:1644-1650 (Pubitemid 32568236)
16. Coli A, Bigotti G, Zucchetti F, Negro F, Massi G: Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia. Histopathology 2002;40:80-87 (Pubitemid 34107385)
17. Oestreicher-Kedem Y, Halpern M, Roizman P, Hardy B, Sulkes J, Feinmesser R, Stern Y: Diagnostic value of galectin-3 as a marker for malignancy in follicular patterned thyroid lesions. Head Neck 2004;26:960-966 (Pubitemid 39488123)
18. Ito Y, Yoshida H, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Nakamura Y, Kakudo K, Kuma K, Miyauchi A: Galectin-3 expression in follicular tumours: An immunohistochemical study of its use as a marker of follicular carcinoma. Pathology 2005;37:296-298 (Pubitemid 41208326)
19. DeLellis RA, Lloyd RV, Heitz PU, Eng C (editors): World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs. Lyon, IARC Press, 2004
20. Sobin LH, Wittekind CH (editors): Thyroid gland. In TNM Classification of Malignant Tumours. Sixth edition. New York, Wiley-Liss, 2002, pp 52-56
21. Kim MJ, Kim HJ, Hong SJ, Shong YK, Gong G: Diagnostic utility of galectin-3 in aspirates of thyroid follicular lesions. Acta Cytol 2006;50:28-34
22. Mehrotra P, Okpokam A, Bouhaidar R, Johnson SJ, Wilson JA, Davies BR, Lennard TW: Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms. Histopathology 2004;45:493-500 (Pubitemid 39524324)
23. Bartolazzi A, Bussolati G: Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms. Histopathology 2006;48:212-213
24. Rosai J: Thyroid gland. In Rosai and Ackerman's Surgical Pathology. Ninth edition. Philadelphia, Mosby Elsevier, 2004, pp 515-594
25. Sanabria A, Carvalho AL, Piana de Andrade V, Pablo Rodrigo J, Vartanian JG, Rinaldo A, Ikeda MK, Devaney KO, Magrin J, Augusto Soares F, Ferlito A, Kowalski LP: Is galectin-3 a good method for the detection of malignancy in patients with thyroid nodules and a cytologic diagnosis of "follicular neoplasm"? A critical appraisal of the evidence. Head Neck 2007;29:1046-1054
26. Nascimento MC, Bisi H, Alves VA, Longatto-Filho A, Kanamura CT, Medeiros-Neto G: Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas. Endocr Pathol 2001;12:275-279 (Pubitemid 34066748)
27. Cole WH: Incidence of carcinoma of the thyroid in nodular goiter. Semin Surg Oncol 1991;7:61-63
28. Pelizzo MR, Toniato A, Piotto A, Bernante P: Cancer in multinodular goiter. Ann Ital Chir 1996;67:351-356